Increased risk for flap dislocation with perioperative brimonidine use in femtosecond laser in situ keratomileusis
Authors:
- Gonzalo MuñozGMGonzalo Muñoz
- César Albarrán-DiegoCACésar Albarrán-Diego
- Hani F. SaklaHSHani F. Sakla
- Jaime JavaloyJJJaime Javaloy
- 1 August 2009
- journal article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 35 (8) , 1338-1342
Abstract
To determine whether brimonidine 0.2% minimizes the occurrence of subconjunctival hemorrhages without inducing postoperative flap complications in femtosecond laser in situ keratomileusis (LASIK). Centro Oftalmológico Marqués de Sotelo and Hospital NISA Virgen del Consuelo, Valencia, Spain. This prospective contralateral-eye interventional study evaluated consecutive patients who had bilateral simultaneous femtosecond LASIK for myopia (spherical equivalent [SE] range −1.00 to −8.00 diopters) performed with an IntraLase femtosecond laser and a Visx Star 2 excimer laser. One eye of each patient received a single drop of brimonidine tartrate 0.2% (brimonidine group) and the other eye, a single drop of a balanced salt solution (control group). The study evaluated 136 eyes (68 patients). The difference in the incidence of subconjunctival hemorrhages was statistically significantly lower in the brimonidine group (mean score 2.24 ± 1.96 [SD]) than in the control group (mean score 7.61 ± 2.72) (P<.001). However, no eye in the control group and 7 eyes (10.4%) in the brimonidine group had a dislocated flap with folds on the first postoperative day (P = .016). All eyes with dislocated flaps required surgical intervention. At 6 months, there was no significant difference between groups in the percentage of eyes achieving 20/20 or better uncorrected distance visual acuity, in the mean SE, or in the enhancement rate. Brimonidine prevented the formation of subconjunctival hemorrhages after femtosecond LASIK but increased the risk for flap dislocation. Thus, surgeons are cautioned against the use of perioperative brimonidine to decrease hemorrhagic complications in femtosecond LASIK.Keywords
This publication has 11 references indexed in Scilit:
- The Use of the Femtosecond Laser in Penetrating KeratoplastyAmerican Journal of Ophthalmology, 2007
- Comparison of outcomes of 2 channel sizes for intrastromal ring segment implantation with a femtosecond laser in eyes with keratoconusJournal of Cataract & Refractive Surgery, 2007
- Topical phenylephrine in laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2007
- Transient light-sensitivity syndrome after laser in situ keratomileusis with the femtosecond laserJournal of Cataract & Refractive Surgery, 2006
- Randomized prospective clinical study comparing induced aberrations with IntraLase and Hansatome flap creation in fellow eyesJournal of Cataract & Refractive Surgery, 2005
- Femtosecond laser versus mechanical keratome flaps in wavefront-guided laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2005
- Comparison of the IntraLase femtosecond laser and mechanical keratomes for laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2004
- Flap dimensions created with the IntraLase FS laserJournal of Cataract & Refractive Surgery, 2004
- LASIK vs LASEK vs PRK: Advantages and indicationsSeminars in Ophthalmology, 2003
- The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rates in laser in situ keratomileusis patients11The authors have no financial or proprietary interest in any product mentioned in this article.Ophthalmology, 2001